albendazole has been researched along with topotecan in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gnoth, MJ; Grieshop, B; Ickenroth, K; Muenster, U | 1 |
1 review(s) available for albendazole and topotecan
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for albendazole and topotecan
Article | Year |
---|---|
PML and a tale of two drug companies.
Topics: AIDS-Related Opportunistic Infections; Albendazole; Blood-Brain Barrier; Camptothecin; Drug Industry; Humans; Irinotecan; JC Virus; Leukoencephalopathy, Progressive Multifocal; Microsporidiosis; Polymerase Chain Reaction; Topotecan | 1995 |
Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions.
Topics: Albendazole; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Binding, Competitive; Cell Line; Cyclosporins; Dibenzocycloheptenes; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Ivermectin; LLC-PK1 Cells; Mice; Quinolines; Ritonavir; Swine; Time Factors; Topotecan; Transfection | 2008 |